🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering products of unknown origin.

Several professionals stated the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.

Service Response and Material Elimination

According to TikTok, the service has removed violative content and prohibited related keywords and query recommendations. The organization said it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.

After moments of joining one community, a vendor shared contact information, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Item Details and Pricing

Within these groups, posts display black plastic parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to possibly significant health risks”.